[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 6, Number 1 (3-2016) ::
Iran J Ped Hematol Oncol 2016, 6(1): 24-31 Back to browse issues page
Clinical Features and Treatment Outcomes of Primary Immune Thrombocytopenic Purpura in Hospitalized Children Under 2-Years Old
Dr H Farhangi, Dr A Ghasemi, Dr A Banihashem, Dr Z Badiei , Dr L Jarahi, Dr G Eslami, Dr T Langaee
Abstract:   (1226 Views)

Abstract
Background
Immune thrombocytopenic purpura (ITP) is the most prevalent cause of thrombocytopenia in children. Despite the importance of ITP in children under 2- years old, only a few publications are available in the literature. ITP usually presents itself as   isolated thrombocytopenia and mucocutaneous bleeding.
Materials and Methods
This study was conducted on 187 under 2- year-old children diagnosed with ITP and treated at Dr. Sheikh Hospital from 2004
to 2011.In this retrospective study, clinical symptoms, laboratory findings, history of viral infections, vaccination history, and
treatment efficacy in children under 2- years old with ITP were investigated.Patients were followed for one year after being discharged from the hospital.
Results
The risk of the disease developing into chronic form was higher in older children (0.001). ITP in children under 3-months
old was significantly associated with vaccination (p=0.007). There was no significant differences between male and female patients in regards to newly diagnosed ITP, persistent, and chronic disease status (p = 0.21). No significant difference in bleeding symptoms was observed between patients under 3-months old and 3 to 24-months old (p=0.18).
Conclusion
Infantile ITP respond favorably to treatment. The risk of the disease developing into chronic form is higher in 3-to-24-month-old children compared to under-three-month olds.

Keywords: ITP, Intravenous Immune Globulin, Pediatric, Platelet, Vaccination.
Full-Text [PDF 125 kb]   (451 Downloads)    
Type of Study: Research | Subject: Special
Received: 2016/02/24 | Accepted: 2016/02/24 | Published: 2016/02/24
Add your comments about this article
Your username or email:

Write the security code in the box >



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Farhangi H, Ghasemi A, Banihashem A, Badiei Z, Jarahi L, Eslami G et al . Clinical Features and Treatment Outcomes of Primary Immune Thrombocytopenic Purpura in Hospitalized Children Under 2-Years Old. Iran J Ped Hematol Oncol. 2016; 6 (1) :24-31
URL: http://ijpho.ssu.ac.ir/article-1-239-en.html
Volume 6, Number 1 (3-2016) Back to browse issues page
Iranian Journal of Pediatric Hematology and Oncology
Persian site map - English site map - Created in 0.211 seconds with 842 queries by yektaweb 3506